Wacky Bob Kennedy and the health officials who work for him are now reevaluating a $590 million contract for bird flu shots ...
The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in ...
Moderna shares fell 3% Thursday afternoon, after reports that federal health officials are re-evaluating the company’s $590 million contract to help develop a bird-flu vaccine. Moderna was awarded the ...
The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.
Moderna Inc.'s stock tumbled 4% Thursday, after a report that health officials are reviewing a contract the company won from the Biden administration to support its efforts to develop a bird-flu ...
A government advisory committee has canceled a meeting on flu shot recommendations, raising concerns amid shifts in ...
18h
Axios on MSNFunding for Moderna bird flu vaccine under reviewThe Trump administration confirmed it's reviewing whether to pull $590 million in funding that Moderna received in the final ...
Moderna (NASDAQ: MRNA) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future.
The FDA canceled a vaccine advisory committee meeting to discuss influenza virus strains that should be included in shots for ...
The administration also told Vaxart Inc. to halt its research on an oral Covid vaccine, Bloomberg reports. In related news, the policy to cull poultry caught in H5N1 bird flu outbreaks will not be ...
U.S. health officials are reevaluating a $590M bird flu vaccine contract that was awarded to Moderna ( NASDAQ: MRNA) by the ...
U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results